BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25996046)

  • 1. Cationic cell-penetrating peptides as vehicles for siRNA delivery.
    Beloor J; Zeller S; Choi CS; Lee SK; Kumar P
    Ther Deliv; 2015; 6(4):491-507. PubMed ID: 25996046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.
    Baoum A; Ovcharenko D; Berkland C
    Int J Pharm; 2012 May; 427(1):134-42. PubMed ID: 21856394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
    Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
    Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptides for siRNA delivery to glioblastomas.
    Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
    Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
    Endoh T; Ohtsuki T
    Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human Disease.
    Dinca A; Chien WM; Chin MT
    Int J Mol Sci; 2016 Feb; 17(2):263. PubMed ID: 26907261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell penetrating peptides: the potent multi-cargo intracellular carriers.
    Kardani K; Milani A; H Shabani S; Bolhassani A
    Expert Opin Drug Deliv; 2019 Nov; 16(11):1227-1258. PubMed ID: 31583914
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
    Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
    Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
    Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
    Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
    Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
    Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal and magnetic dual-responsive liposomes with a cell-penetrating peptide-siRNA conjugate for enhanced and targeted cancer therapy.
    Yang Y; Xie X; Xu X; Xia X; Wang H; Li L; Dong W; Ma P; Yang Y; Liu Y; Mei X
    Colloids Surf B Biointerfaces; 2016 Oct; 146():607-15. PubMed ID: 27429294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.
    Xie X; Lin W; Li M; Yang Y; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
    Ultrasound Med Biol; 2016 Jun; 42(6):1362-74. PubMed ID: 27012462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
    Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X
    Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
    Li H; Tsui TY; Ma W
    Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
    Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
    Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-cell penetrating peptide-based fusion proteins for siRNA delivery.
    Li H; Tsui T
    Drug Deliv; 2015 May; 22(3):436-43. PubMed ID: 24491156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.